Creative Biolabs-Immuno-oncology

Anti-CD22 (clone IRO31) SynExpress T7-R-β-N NK Cells (CAT#: ITS-1124-CR14)

DatasheetDatasheet
Description
This product utilizes NK cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO31). We employs the pUC (T7-RFP-β-catenin-NotI) vector components and the SynExpress system of the introns Substitution/Adaptive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO31
Species Reactivity
Human
Cell Source
NK cells
Sensor Gene
RFP
Promoter
T7
Effector Gene
β-catenin
Insertion Sites
NotI
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
pUC
Transformation Accuracy
0.92
Cell Culture
Plate Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.